Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer

Details for Australian Patent Application No. 2006265835 (hide)

Owner Amgen Inc.

Inventors Liu, Longbin; Patel, Vinod F.; D'Angelo, Noel; Kim, Joseph L.; Fellows, Ingrid M.; Booker, Shon; Tasker, Andrew; Germain, Julie; Kim, Tae-Seong; Dominguez, Celia; Lee, Matthew; Bellon, Steven; Harmange, JeanChristophe; Harvey, Timothy S.

Agent Shelston IP

Pub. Number AU-B-2006265835

PCT Pub. Number WO2007/005668

Priority 60/696,389 30.06.05 US

Filing date 29 June 2006

Wipo publication date 11 January 2007

Acceptance publication date 3 May 2012

International Classifications

C07D 215/04 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4035 (2006.01)

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4725 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2007/005668 Priority application(s): WO2007/005668

3 May 2012 Application Accepted

  Published as AU-B-2006265835

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265840-Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors

2006265823-Card scrambling device